ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001